Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects

Completed · Phase 1

Conditions studied: Postoperative Complications, Constipation

In brief

This is the first multiple-dose experience in humans with MOA-728 in an oral formulation. This study will provide an assessment of the safety, tolerability, and pharmacokinetics (PK) of MOA-728 following administration of ascending multiple oral doses to healthy subjects.

Key facts

Study ID

NCT00311350

Run by

Bausch Health Americas, Inc.

People needed

48

Starts

2006-03-01

Expected to finish

2006-08-01

Last updated by the study team

2019-11-25

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy men and women

Where it is running

• Study site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.